The ALPPS Approach for Colorectal Liver Metastases: Impact of KRAS Mutation Status in Survival

Digestive Surgery

Volumn 35, Issue 4, 2018, Pages 303-310

  Serenari, Matteo ^a,b   Alvarez, Fernando Andres ^b   Ardiles, Victoria ^b   De Santibañes, Martin ^b   Pekolj, Juan ^b   De Santibañes, Eduardo ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Associating liver partition and portal vein occlusion for staged hepatectomy; Colorectal liver metastases; Genetic mutations; Kirsten rat sarcoma viral oncogene homolog; Posthepatectomy liver failure; Survival

Indexed keywords

KRAS PROTEIN, HUMAN; PROTEIN P21;

ADULT; AGED; BLOOD; COLORECTAL TUMOR; FEMALE; GENETICS; HEPATIC PORTAL VEIN; HUMAN; LIVER; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; MUTATION; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PATIENT SELECTION; PORTAL VEIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS P21(RAS); RETROSPECTIVE STUDIES;

EID: 85031793557     PISSN: 02534886     EISSN: 14219883     Source Type: Journal    
DOI: 10.1159/000471930     Document Type: Article

References (31)

1. Alvarez FA, Sanchez Claria R, Oggero S, de Santibanes E: Parenchymal-sparing liver surgery in patients with colorectal carcinoma liver metastases. World J Gastrointest Surg 2016; 8: 407-423.
2. Mise Y, Sakamoto Y, Ishizawa T, Kaneko J, Aoki T, Hasegawa K, et al: A worldwide survey of the current daily practice in liver surgery. Liver cancer 2013; 2: 55-66.
3. Yang C, Rahbari NN, Mees ST, Schaab F, Koch M, Weitz J, et al: Staged resection of bilobar colorectal liver metastases: surgical strategies. Langenbecks Arch Surg 2015; 400: 633-640.
4. Schadde E, Ardiles V, Slankamenac K, Tschuor C, Sergeant G, Amacker N, et al: ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg 2014; 38: 1510-1519.
5. Serenari M, Zanello M, Schadde E, Toschi E, Ratti F, Gringeri E, et al: Importance of primary indication and liver function between stages: results of a multicenter Italian audit of ALPPS 2012-2014. HPB (Oxford) 2016; 18: 419-427.
6. Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M, et al: Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry. Ann Surg 2015; 262: 780-785; discussion 785-786.
7. Oldhafer KJ, Donati M, Jenner RM, Stang A, Stavrou GA: ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence. World J Surg 2014; 38: 1504-1509.
8. Adam R, Imai K, Castro Benitez C, Allard MA, Vibert E, Sa Cunha A, et al: Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases. Br J Surg. 2016; 103: 1521-1529.
9. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318; discussion 318-321.
10. Andreatos N, Ronnekleiv-Kelly S, Margonis GA, Sasaki K, Gani F, Amini N, et al: From bench to bedside: clinical implications of KRAS status in patients with colorectal liver metastasis. Surg Oncol 2016; 25: 332-338.
11. Brudvik KW, Kopetz SE, Li L, Conrad C, Aloia TA, Vauthey JN: Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. Br J Surg 2015; 102: 1175-1183.
12. Alvarez FA, Ardiles V, de Santibanes M, Pekolj J, de Santibanes E: Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg 2015; 261: 723-732.
13. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
14. Kambakamba P, Linecker M, Alvarez FA, Samaras P, Reiner CS, Raptis DA, et al: Short chemotherapy-free interval improves oncological outcome in patients undergoing twostage hepatectomy for colorectal liver metastases. Ann Surg Oncol 2016; 23: 3915-3923.
15. de Santibanes E, Alvarez FA, Ardiles V, Pekolj J, de Santibanes M: Inverting the ALPPS paradigm by minimizing first stage impact: the mini-ALPPS technique. Langenbecks Arch Surg 2016; 401: 557-563.
16. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al: The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187-196.
17. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al: Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 2011; 149: 713-724.
18. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al: Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-722; discussion 722-724.
19. Margonis GA, Sasaki K, Kim Y, Samaha M, Buettner S, Amini N, et al: Tumor biology rather than surgical technique dictates prognosis in colorectal cancer liver metastases. J Gastrointest Surg 2016; 20: 1821-1829.
20. Brudvik KW, Mise Y, Chung MH, Chun YS, Kopetz SE, Passot G, et al: RAS mutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol 2016; 23: 2635-2643.
21. Hallet J, Sa Cunha A, Adam R, Goere D, Bachellier P, Azoulay D, et al: Factors influencing recurrence following initial hepatectomy for colorectal liver metastases. Br J Surg 2016; 103: 1366-1376.
22. Imai K, Allard M-A, Benitez CC, Vibert E, Sa Cunha A, Cherqui D, et al: Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors? Oncologist 2016; 21: 887-894.
23. Oba M, Hasegawa K, Matsuyama Y, Shindoh J, Mise Y, Aoki T, et al: Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: a potential surrogate endpoint for time to surgical failure. Ann Surg Oncol 2014; 21: 1817-1824.
24. Torzilli G, Procopio F, Botea F, Marconi M, Del Fabbro D, Donadon M, et al: One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach. Surgery 2009; 146: 60-71.
25. Vigano L, Procopio F, Cimino MM, Donadon M, Gatti A, Costa G, et al: Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An observational cohort. Ann Surg Oncol 2016; 23: 1352-1360.
26. Lam VW, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ: A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford) 2013; 15: 483-491.
27. Giuliante F, Ardito F, Ferrero A, Aldrighetti L, Ercolani G, Grande G, et al: Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients. J Am Coll Surg 2014; 219: 285-294.
28. Vigano L, Torzilli G, Cimino M, Imai K, Vibert E, Donadon M, et al: Drop-out between the two liver resections of two-stage hepatectomy. Patient selection or loss of chance? Eur J Surg Oncol 2016; 42: 1385-1393.
29. Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, et al: Early survival and safety of ALPPS: first report of the international ALPPS registry. Ann Surg 2014; 260: 829-836; discussion 836-838.
30. Abbott DE, Sohn VY, Hanseman D, Curley SA: Cost-effectiveness of simultaneous resection and RFA versus 2-stage hepatectomy for bilobar colorectal liver metastases. J Surg Oncol 2014; 109: 516-520.
31. Faitot F, Faron M, Adam R, Elias D, Cimino M, Cherqui D, et al: Two-stage hepatectomy versus 1-stage resection combined with radiofrequency for bilobar colorectal metastases: a case-matched analysis of surgical and oncological outcomes. Ann Surg 2014; 260: 822-827; discussion 827-828